Learn
Precision Prostate Cancer Screening: Moving From One-Size-Fits-All to Risk Stratified Prevention
Recent studies show that genomic risk modelling can refine prostate cancer screening by combining polygenic risk scores, family history, and genetic ancestry. This risk stratified approach enables more precise identification of individuals at higher risk while reducing unnecessary testing for lower-risk patients.
From Eligibility Criteria to Preventive Insight: The Expanding Role of Population Genomics
A pilot population genomic screening program in Australia revealed that nearly 2% of young adults carry pathogenic variants missed by traditional guidelines. Structured interpretation, reporting, and counselling help ensure early, preventive care for at-risk individuals.